Revenue, Gross Profit and Operating Income (Loss) by Reportable Segment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Revenue	$ 881,662	$ 860,903	$ 706,793
Gross Profit	399,897	378,472	300,328
Operating Income (Loss)	110,496	103,079	64,054
Operating Segments | Precision Medicine and Manufacturing
Segment Reporting Information [Line Items]
Revenue	282,971	274,674	232,459
Gross Profit	139,060	129,173	107,993
Operating Income (Loss)	69,283	63,760	46,792
Operating Segments | Medical Solutions
Segment Reporting Information [Line Items]
Revenue	325,221	277,992	262,060
Gross Profit	135,640	108,713	100,890
Operating Income (Loss)	41,883	28,244	17,694
Operating Segments | Robotics and Automation
Segment Reporting Information [Line Items]
Revenue	273,470	308,237	212,274
Gross Profit	130,885	146,150	99,345
Operating Income (Loss)	48,373	60,294	52,676
Unallocated Corporate and Shared Services
Segment Reporting Information [Line Items]
Gross Profit	(5,688)	(5,564)	(7,900)
Operating Income (Loss)	$ (49,043)	$ (49,219)	$ (53,108)